DehydraTECH-semaglutide reduced overall side effects by 48% as compared to Rybelsus® DehydraTECH-semaglutide reduced gastrointestinal side effects by 55% as compared to Rybelsus® Recent financings ...

The FDA greenlights treatment-related changes in bone mineral density as a surrogate endpoint in anti-osteoporosis drug trials in postmenopausal women.

Minimal residual disease is “a credible intermediate endpoint” for some patients with newly diagnosed acute myeloid leukemia, researchers report.

Entera Bio (ENTX) congratulates the FNIH-ASBMR-SABRE team following the Food and Drug Administration broad qualification of total hip bone mineral ...

Endpoint management has become more challenging for IT teams as organisations adopt remote work, cloud services, and a wider ...

We feature the best endpoint protection software, to make it simple and easy to protect and manage security on mobile devices as well as desktops. Endpoint detection and response works by monitoring ...

Autonomous Endpoint Management, or AEM, blends unified endpoint management, digital employee experience, and AI to enable comprehensive, autonomous management of endpoints. Tanium, a leader in ...

Lexaria Bioscience (LEXX) provides the following final primary and major secondary efficacy endpoint results update on its Phase 1b, 12-week ...